Author Details

Fomin, V V

Issue Section Title File
No 1 (2009) Articles Albuminuria as a marker of kidney injury and cardiovascular risk
No 2 (2009) Articles ACE inhibitors and nephroprotection in chronic proteinuric nephropathies
No 1 (2009) Articles Direct renin inhibitor aliskiren - new opportunities of kidney protection at hypertensive patients
No 2 (2009) Articles Russian registry of resistant arterial hypertension (REGATTA): study design
No 1 (2010) Articles RENAL FAILURE IN FABRY DISEASE: POSSIBILITY OF RADICAL IMPROVEMENT OF PROGNOSIS
No 1 (2009) Articles Atherosclerotic stenosis of the sole functioning kidney artery in patient with diabetes mellitus type 2 as a variant of kidney multimorbidity inelderly
No 4 (2009) Articles CLINICAL SIGNIFICANCE OF DETERMINATION OR URINARY CONCENTRATION OF ENDOTHELIAL DYSFUNCTION AND FIBROGENESIS MARKERS IN HYPERTENSIVE NEPHROPATHY
No 3 (2009) Articles Can we manage arterial hypertension without hydrochlorothiazide?
No 2 (2009) Articles Optimization of loop diuretic therapy in chronic heart failure and chronic kidney disease
No 1 (2009) Articles Controversies in ACE inhibitors use
No 3 (2009) Articles Multiple renal arteries as a cause of resistant arterial hypertension
No 1 (2010) Articles LOOP DIURETICS AND ANTIHYPERTENSIVE TREATMENT: FORGOTTEN PAST OR REAL PERSPECTIVE?
No 4 (2009) Articles FROM SARALASIN TO SARTANS: HISTORY OF THE ANGIOTENSIN II RECEPTOR BLOCKADE
No 3 (2009) Articles The HOPE Study: putting it's experience into clinical practice
No 4 (2009) Articles FROM HOPE STUDY TO HOPE-2 AND HOPE-TOO STUDIES: DOES EXISTING PREVENTION STRATEGIES ARE NEED RADICAL IMPROVEMENT?
No 4 (2010) Articles REKOMENDATsII EVROPEYSKOGO OBShchESTVA PO ARTERIAL'NOY GIPERTENZII VERSII 2009 GODA: ChTO IZMENILOS'?
No 1 (2010) Articles TO WHAT LEVEL WE MUST DECREASE SYSTOLIC BLOOD PRESSURE IN HYPERTENSIVE PATIENTS NOT SUFFERING FROM TYPE 2 DIABETES MELLITUS?
No 2 (2010) Articles Perspectives on long-acting dihydropiridine calcium antagonists in treatment and prophylaxis of chronic kidney disease
No 4 (2010) Articles VICh-ASSOTsIIROVANNAYa NEFROPATIYa: STRATEGIYa DIAGNOSTIKI I LEChENIYa
No 4 (2010) Articles PRYaMOY INGIBITOR RENINA ALISKIREN - SAMOSTOYaTEL'NAYa STRATEGIYa KORREKTsII KARDIORENAL'NOGO SINDROMA PRI METABOLIChESKOM SINDROME I OZhIRENII
No 6 (2010) Articles CHRONIC KIDNEY DISEASE AND ATRIAL FIBRILLATION
No 1 (2011) Articles ASSOCIATION OF LEPTINEMIA AND ADIPONECTINEMIA WITH CHRONIC KIDNEY DISEASE IN PATIENTS WITH METABOLIC SYNDROME AND NON-ALCOHOLIC FATTY LIVER DISEASE
No 5 (2010) Articles Peculiarities of IgA-nephropathy clinical course, associated with excess body mass weight
No 3 (2011) Articles Drug-induced kidney disease in HIV-infected patients: clinical variants, approaches to prevention
No 5 (2010) Articles FREQUENT PITFALLS IN ANTIHYPERTENSIVE THERAPY
No 5 (2010) Articles Fabry disease with proteinuric nephropathy and hypertrophic cardiomyopathy, misinterpreted as chronic glomerulonephritis in Schonlein-Henoch purpura
No 2 (2011) Articles Lupus nephritis, associated with skin involvement, mimicking porphyria cutanea tarda
No 4 (2011) Articles CARDIO-RENAL ANEMIA SYNDROME: CORRECTION WITH IRON SUCROSE
No 6 (2011) Articles CLINICAL SIGHNIFICANCE OF ADIPONECTINEMIA IN DEVELOPMENT OF TARGET ORGAN-DAMAGE IN METABOLIC SYNDROME, ASSOCIATED WITH NON-ALCOHOLIC FATTY LIVER DISEASE
No 6 (2011) Articles Cardiomyopathy in anemia, associated with chronic kidney disease: role of erythropoetin-beta
No 5 (2011) Articles SUCCESFUL RITUXIMAB THERAPY OF MEMBRANOUS NEPHROPATHY, RESISTANT TO STANDARD IMMUNOSUPRESSIVE TREATMENT
No 1 (2012) Articles Polymorphism of podocyte protein genes in nephrotic glomerulonephritis, resistant to standard regimens of immunosupressive therapy
No 1 (2012) Articles SEVERE PODOCYTE DAMAGE IN ASYMPTOMATIC PATIENT WITH FABRY DISEASE
No 4 (2015) Articles Diagnosis and treatment of arterial hypertension in chronic kidney disease
No 4 (2015) Articles The issue of resistant hypertension in chronic glomerulonephritis

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies